Tianjiao Chu

Tianjiao Chu

Auto-generated profile, based on publicly available information

Tianjiao Chu

Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
OBOfer Beharier
Ofer Beharier
VTVladimir A. Tyurin
Vladimir A. Tyurin
JGJulie P. Goff
Julie P. Goff
JGJennifer Guerrero-Santoro
Jennifer Guerrero-Santoro
KKKazuhiro Kajiwara
Kazuhiro Kajiwara
YSYoel Sadovsky
Yoel Sadovsky
Significance: Placental dysfunction has been causally linked to major pregnancy complications that are implicated in maternal–fetal morbidity and mortality, but the mechanisms underlying placental dysfunction are largely unknown. The recently identified ferroptotic cell death is characterized by excessive accumulation of hydroperoxide phosphatidylethanolamines. While oxidative damage commonly defines placental dysfunction, the role of ferroptosis in this process is largely unknown. We found that preterm birth is associated with ferroptotic signals, and that inhibition of GPX4, which converts unstable lipid hydroperoxides to nontoxic lipid alcohols, causes ferroptotic injury in primary human trophoblasts and in mouse pregnancy. Importantly, we found that the phospholipase PLA2G6 mitigates trophoblast and placental ferroptosis. Together, we identified placental ferroptosis and established a role for PLA2G6 in attenuating ferroptosis.

28 April 2021 in mSphere
Verified
Journal Article
Open access
PDF file
YOYingshi Ouyang
Yingshi Ouyang
TBTarique Bagalkot
Tarique Bagalkot
WFWendy Fitzgerald
Wendy Fitzgerald
ESElena Sadovsky
Elena Sadovsky
TCTianjiao Chu
Tianjiao Chu
YSYoel Sadovsky
Yoel Sadovsky
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had a massive impact on human lives worldwide. While the airborne SARS-CoV-2 primarily affects the lungs, viremia is not uncommon. As placental trophoblasts are directly bathed in maternal blood, they are vulnerable to SARS-CoV-2. Intriguingly, the human fetus is largely spared from SARS-CoV-2 infection. We tested whether the human placenta expresses the main SARS-CoV-2 entry factors angiotensin-converting enzyme 2 (ACE2), transmembrane protease serine 2 (TMPRSS2), and furin and showed that ACE2 and TMPRSS2 are expressed in the trophoblast rather than in other placental villous cells. While furin is expressed in the main placental villous cell types, we surveyed, trophoblasts exhibit the highest expression. In line with the expression of these entry factors, we demonstrated that a SARS-CoV-2 pseudovirus could enter primary human trophoblasts. Mechanisms underlying placental defense against SARS-CoV-2 infection likely involve postentry processing, which may be germane for mitigating interventions against SARS-CoV-2. IMPORTANCE Pregnant women worldwide have been affected by COVID-19. As the virus is commonly spread to various organs via the bloodstream and because human placental trophoblasts are directly bathed in maternal blood, feto-placental infection by SARS-CoV-2 seems likely. However, despite the heightened risk to pregnant women, thus far the transmission risk of COVID-19 to the feto-placental unit seems extremely low. This has been recently attributed to a negligible expression of SARS-CoV-2 entry factors in the human placenta. We therefore sought to explore the expression of the entry factors ACE2 and TMPRSS2 in the different cell types of human placental villi. Using a combination of transcriptome sequencing (RNA-seq), real-time quantitative PCR (RT-qPCR), in situ hybridization, and immunofluorescence, we found that trophoblasts, but not the other main villous cell types, express ACE2 and TMPRSS2, with a broad expression of furin. Correspondingly, we also showed that primary human trophoblasts are permissive to entry of SARS-CoV-2 pseudovirus particles.

27 April 2021 in Epigenomics
Verified
Journal Article
Open access
MGMisty Good
Misty Good
TCTianjiao Chu
Tianjiao Chu
PSPatricia Shaw
Patricia Shaw
LNLila Nolan
Lila Nolan
LMLora McClain
Lora McClain
DPDavid G Peters
David G Peters
Aim: Neonatal necrotizing enterocolitis (NEC) is a deadly and unpredictable gastrointestinal disease, for which no biomarker exists. We aimed to describe the methylation patterns in stool and colon...

19 November 2020 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
KKKamil Krawczyński
Kamil Krawczyński
YOYingshi Ouyang
Yingshi Ouyang
JMJean-Francois Mouillet
Jean-Francois Mouillet
TCTianjiao Chu
Tianjiao Chu
CCCarolyn Coyne
Carolyn Coyne
YSYoel Sadovsky
Yoel Sadovsky
The function of microRNAs (miRNAs) can be cell autonomous or communicated to other cell types, and has been implicated in diverse biological processes. We previously demonstrated that miR-517a-3p (miR-517a), the highly expressed member of the chromosome 19 miRNA cluster (C19MC) that are transcribed almost exclusively in human trophoblasts, attenuates viral replication via induction of autophagy in non-trophoblastic, recipient cells. However, the molecular mechanisms underlying these effects remain unknown. Here we identified Unc-13 homologue D (UNC13D) as a direct, autophagy-related gene target of miR-517a, leading to repression of UNC13D. In line with the antiviral activity of miR-517a, silencing UNC13D suppressed replication of vesicular stomatitis virus (VSV), whereas overexpression of UNC13D increased VSV levels, suggesting a role for UNC13D silencing in the antiviral activity of miR-517a. We also found that miR-517a activated NFκB signaling in HEK-293XL cells expressing TLR8, but the effect was not-specific to C19MC miRNA. Together, we define mechanistic pathways that link C19MC miRNA with inhibition of viral replication.

18 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
GAGeorgia Rae J Atkins
Georgia Rae J Atkins
RHRachel L. Hvasta-Gloria
Rachel L. Hvasta-Gloria
CDChatchanan Doungkamchan
Chatchanan Doungkamchan
CPChristopher R. Pombar
Christopher R. Pombar
JHJimmaline J. Hardy
Jimmaline J. Hardy
KOKyle E. Orwig
Kyle E. Orwig
Non-obstructive azoospermia (NOA) is the absence of sperm in the ejaculate due to spermatogenic failure. Fifty percent of NOA cases are unexplained but may arise from unidentified genetic mutations. Variants in TEX11 have been identified in men with NOA; and Tex11 knockout in mice causes NOA. Here we attempt to validate three TEX11 variants discovered in NOA patients by knocking them into the orthologous region of the mouse genome using CRISPR/Cas9 gene editing. Compared to wild type (144.2 ± 9.87 mg; 1.7 ± 0.5 million sperm/cauda epididymis 4.8 ± 1.3 pups/breeding), Tex11D mice (frameshift mutation) had reduced testis weight (28.33 ± 1.16 mg); no sperm in the epididymis; and were infertile with a maturation arrest testicular phenotype. We did not observe any spermatogenesis or fertility defects Tex11A mice (missense mutation). Tex11L mice had reduced testis weight (87.5 ± 14.79 mg) and epididymal sperm counts (0.33±0.13 million/cauda epididymis) but an incompletely penetrant infertility phenotype (5.4 ± 1.13 pups/breeding) with one third of mice being infertile. Infertile Tex11L mice also had a distinct epididymal phenotype with reduced sperm density in the caput and no sperm in the cauda, which was filled with amorphous material.

23 December 2025 in Molecular Human Reproduction
Verified
Journal Article
Closed access
YWYucheng Wang
Yucheng Wang
PSPatricia A Shaw
Patricia A Shaw
CBCamille K Boufford
Camille K Boufford
ADAshley C Davis
Ashley C Davis
ELElizabeth Lewis
Elizabeth Lewis
DPDavid G Peters
David G Peters
Endometriosis (EM) is a debilitating disease involving the growth of endometrial glands and stroma outside the uterus. To further our understanding of epigenomic dysregulation in EM and search for disease biomarkers, we performed a comprehensive evaluation of DNA methylation in eutopic endometrium (EE) and EM lesions. We undertook deconvolution analysis of DNA methylation data previously generated from endometrial aspirate biopsies obtained from 637 EM cases and 347 controls using microarray-based DNA methylation analysis. We further analyzed DNA methylation in EM lesions and paired EE samples via solution phase hybridization and DNA sequencing. For analysis of microarray data, we used a reference-free approach (BCconf) to recover latent factors and found high correlation with EM status, suggesting EE cell proportions vary between EM cases and controls. Deconvolution revealed that epithelial cells (P-value = 9.1 × 10−3) and fibroblasts (P-value = 0.022) were reduced in EM cases. Deconvolution of the sequencing data identified differences between EM lesions and EE of cases and controls, including vascular endothelial cells (false discovery rate [FDR]-adjusted P-value = 6.1 × 10−3; more abundant in EM lesions), natural killer cells (FDR-adjusted P-value = 0.031; less abundant in EM lesions) and ovarian/endometrial epithelium (FDR-adjusted P-value = 3.2 × 10−3). We detected significant differences in cell type proportion between EE samples of cases and controls. Improved reference data for deconvolution to inform more intelligent region targeting approaches will provide further insight into the molecular phenotype of EM and may inform novel approaches for minimally invasive detection.